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Abstract
Measles virus (MV) is a highly contagious virus that is transmitted by aerosols. During systemic infection, CD150+ T and B
lymphocytes in blood and lymphoid tissues are the main cells infected by pathogenic MV. However, it is unclear which cell
types are the primary targets for MV in the lungs and how the virus reaches the lymphoid tissues. In vitro studies have
shown that dendritic cell (DC) C-type lectin DC-SIGN captures MV, leading to infection of DCs as well as transmission to
lymphocytes. However, evidence of DC-SIGN-mediated transmission in vivo has not been established. Here we identified
DC-SIGNhi DCs as first target cells in vivo and demonstrate that macaque DC-SIGN functions as an attachment receptor for
MV. Notably, DC-SIGNhi cells from macaque broncho-alveolar lavage and lymph nodes transmit MV to B lymphocytes,
providing in vivo support for an important role for DCs in both initiation and dissemination of MV infection.
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Introduction
Measles virus (MV) is a highly contagious virus, transmitted via
the respiratory route. Despite the availability of a safe and effective
vaccine and increased vaccination coverage, measles outbreaks are
still associated with high levels of childhood mortality [1]. Clinical
symptoms appear approximately two weeks after MV infection
and are associated with a profound immune suppression that lasts
for several weeks to months and leads to enhanced susceptibility to
opportunistic infections [2,3].
The entry receptor for wild-type MV is CD150 (signaling
lymphocyte activation molecule or SLAM) [4], expressed mainly
by subsets of B and T lymphocytes and dendritic cells (DCs).
Recently, Poliovirus-receptor-like-4 (PVRL4 or Nectin-4) was
identified as the epithelial entry receptor. This protein is
exclusively expressed on the basolateral side of epithelial cells
and usage of this receptor is associated with late stages of disease
progression and host-host transmission [5,6]. Macaque infection
studies demonstrated that MV is detected at the peak of infection
in the lungs, peripheral blood mononuclear cells (PBMC) and all
lymphoid tissues [7–9]. We have shown in in vivo studies using
a pathogenic recombinant (r)MV expressing enhanced green
fluorescent protein (EGFP) that memory CD150+ B and T
lymphocytes are the predominant cells infected in blood and
lymph nodes during the peak of infection [10,11]. However, it
remains unclear which cells are the first target cells after aerosol
infection and how the virus is disseminated from lungs to the
lymphoid tissues.
Dendritic cells (DCs) have been suggested to play an important
role in virus transmission. DCs are professional antigen presenting
cells that migrate to lymph nodes upon encountering pathogens
and induce a pathogen-specific immune response [12]. Besides
playing a pivotal role in shaping the immune response to MV
[3,13–16], DCs have also been suggested to transmit MV to
lymphocytes [13]. Several in vitro studies have shown that DCs
efficiently transmit viruses such as HIV-1 and MV to lymphocytes
[13,17], but little is known about virus transmission in vivo.
The C-type lectin Dendritic Cell-Specific Intercellular adhesion
molecule-3-Grabbing Non-integrin (DC-SIGN) is an attachment
receptor for MV [13,18]. DC-SIGN has a high affinity for
mannose containing structures, including glycosylated viral
proteins such as human immunodeficiency virus (HIV) type 1
gp120 [17,19] and the MV fusion (F) and hemagglutinin (H)
transmembrane glycoproteins [13]. In vitro models demonstrate
that interaction of MV with human DC-SIGN enhances DC
infection as well as transmission of MV from DCs to both CD4+
and CD8+ T cells. MV transmission can occur independent of DC
infection (in trans) through capture of the virus and transmission to
target cells [18]. Due to the widespread distribution of DC-SIGN+
DCs throughout the respiratory tract [18] and their capacity for
viral transmission, DCs have been suggested as key players in
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initiating MV infection of the host and disseminating the virus
from the first site of infection to local or draining lymphoid tissues.
However, it is not known whether DC-SIGN is involved in virus
transmission in vivo.
We recently studied the early events after MV infection of
macaques with the pathogenic rMVKSEGFP strain via aerosol
inhalation. EGFP-positive cells were exclusively detected in the
alveolar lumen or attached to the alveolar epithelium of the lungs
2 days post-infection (d.p.i.). From 3 d.p.i. clusters of MV-infected
cells were detected in bronchus-associated lymphoid tissue (BALT)
and in the tracheo-bronchial lymph nodes (TBLN) [20]. The
initial target cells morphologically resembled either DCs or
alveolar macrophages (AM), but their identity and role in viral
transmission remained unknown. In order to gain more un-
derstanding of the in vivo function of DCs in measles, we here
investigated the phenotype of the first target cells and their
function in the early stages of MV infection.
After aerosol infection with the pathogenic rMVKSEGFP strain,
we observed that DC-SIGNhi cells in the lungs and lung-draining
lymph nodes of non-human primates were among the first MV-
infected cells. Ex vivo cultured lung tissue from infected animals
showed focal infection that spread outward during culture and
after 8 days most infected cells were T lymphocytes, suggesting
that DC-SIGNhi cells in lungs are a first target and transmit the
virus to lymphocytes after initial infection. Furthermore, isolated
DC-SIGNhi DCs interacted with MV and were able to transmit
the virus to lymphocytes more efficiently than DC-SIGN- cells.
Our data strongly suggest an important role for DC-SIGN in
dissemination of and infection with measles virus in vivo.
Results
DC-SIGN+ Cells are Early Target Cells in Lungs and
Tracheo-bronchial Lymph Nodes
Cynomolgus macaques were infected with a high dose (106
TCID50) of rMV
KSEGFP by aerosol inhalation [20]. To in-
vestigate the role of DCs during early MV infection, we analyzed
DC-SIGN, HLA-DR and EGFP expression of broncho-alveolar
lavage (BAL) cells collected 2–5 d.p.i. The size of the DC-SIGNhi/
HLA-DR+ and DC-SIGNlo/HLA-DR+ cell subpopulations in the
total BAL population remained stable and relative numbers in the
total population at 4 d.p.i were 16.1% 64.5 and 18.8% 64.5,
respectively. These subpopulations represented the antigen pre-
senting cells, whereas the DC-SIGN2/HLA-DR- cells included the
lymphocytes. We were unable to detect any macroscopic
fluorescence at day 2 d.p.i. [20] and therefore measured infection
by EGFP using flow cytometry, the number of MV-infected cells
detected was in the same range as previously reported [20].
EGFP+ DC-SIGNhi cells were detected in 2/3 animals at the
earliest time point, 2 d.p.i., whereas no EGFP+ DC-SIGNlo/HLA-
DR+ cells were present on day 2 (Figure 1A). In 1/3 animals, few
(,10/106 BAL cells) DC-SIGN2/HLA-DR- infected cells were
identified in BAL on 2 d.p.i. Low numbers of MV-infected cells
and low levels of replication 2 d.p.i. did not allow for detection of
MV-captured Ag independent of infection on DCs. These data
indicate that the DC-SIGN+ cell population is among the first to
become infected by MV. From 3 d.p.i. onwards, EGFP+ DC-
SIGNhi cells were detected in all animals (n = 3 per time point) and
the number of MV-infected cells increased over time. Similarly,
the infection of DC-SIGNlo/HLA-DR+ as well as DC-SIGN2/-
HLA-DR- cells increased over time, suggesting that the virus was
disseminated to these populations.
At 3 d.p.i. live agarose-inflated lung slices from 2 animals were
cultured to visualize infection over time (Figure 1B). Small areas of
EGFP fluorescence were visible after culture for 3 days demon-
strating MV infection of single cells that spread throughout the
tissue, since a clear focal spread of MV was observed the next 7
days. After 5 days of culture, cells emigrating from the tissue into
the supernatant were analyzed for immune cell markers to
determine the phenotype of MV-infected cells. The total
population consisted mainly of cells negative for lymphocyte or
DC markers (Figure 1C). In contrast, more than 70% of the
EGFP+ population cells were CD3+ (T lymphocytes), whereas
EGFP+ DC-SIGN+/HLA-DR+ (DCs) and CD20+ cells (B
lymphocytes) were also identified (Figure 1D). Together, these
data suggest that DC-SIGN+ cells in the lungs are a target for MV
at the earliest time points of infection. At later time points DC-
SIGN2/HLA-DR- cells (mainly T-lymphocytes) became the
predominant MV-infected cell-population.
We next analyzed the localization of DC-SIGN+ cells in the
lungs. In lung tissue from both uninfected and 2 d.p.i, DC-SIGN
expression was mainly detected on cells with irregular, DC-like
morphology located in close proximity of the lumen and large
round cells lining the alveolar lumen (Figure 1E and F), suggesting
that DC-SIGNhi cells can encounter inhaled viral particles,
explaining their infection at the earliest time point.
Next we investigated the appearance of infected cells in the lung
draining TBLNs. Single cell suspensions of TBLNs collected 2, 4
or 5 d.p.i. were analyzed for EGFP, HLA-DR and DC-SIGN
expression (Figure 2). We could not detect any MV-infected cells
in TBLN 2 d.p.i. MV-infected DC-SIGNhi/HLA-DR+ cells, DC-
SIGNlo/HLA-DR+ cells as well as DC-SIGN2/HLA-DR- cells
were detected 4 d.p.i. and the number of infected cells increased at
day 5 in all three subsets. These data suggest that DC-SIGN-
hiHLA-DR+ cells are an initial target for MV in the lung at day 2
and dissemination from lung to draining TBLN occurs after day 2
and results in infection of antigen-presenting cell and lymphocyte
populations.
Phenotype of DC-SIGN+ Cells in Macaques
In order to study the role of DC-SIGN+ cells in lymphoid tissue
in macaques, we characterized these cells by flow cytometry and
immunofluorescence microscopy. Cells isolated from TBLNs of
uninfected animals were stained for DC-SIGN and multiple
monocyte markers: HLA-DR, DC-marker CD11c, DC matura-
tion marker CD83, and macrophage scavenger receptor CD163.
All DC-SIGN+ cells expressed HLA-DR, whereas CD11c and
CD83 were only expressed by part of the DC-SIGN+ population
(Figure 3A). However, DC-SIGN was expressed by almost all
CD83+ and CD11c+ cells (Figure 3B). In addition, we identified
a small subset of CD163+ cells in the TBLN that was partially
positive for DC-SIGN (Figure 3A). These data suggest that DC-
SIGN is expressed by all CD11c+ and CD83+ DCs as well as
a subset of macrophages in macaques.
Next we analyzed distribution of DC-SIGN+ DCs and
macrophage marker MAC387+ macrophages in both lungs and
draining lymph nodes from infected macaques. Because EGFP-
expressing rMV was used, unstained infected sections served as
control besides isotype controls, and gave no signal in the EGFP
channel. In lung sections collected 2 or 3 d.p.i. almost no co-
localization was observed between DC-SIGN and MAC387. Most
large cells near the alveolar lumen were either DC-SIGN+
(Figure 3Ci) or MAC387+ (Figure 3Cii). Some co-localization as
seen in TBLN was observed (Figure 3Ciii and iv). In addition,
many DC-SIGN+ cells were observed in peripheral lymphoid
tissues, including axillary lymph nodes (Figure 3D) and tonsils
(data not shown), at 4–5 d.p.i. the time at which infection just
reached a systemic phase [20]. Thus it seems that infection of
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lymphoid tissue is associated with abundant numbers of DC-
SIGN+ cells in lymphoid tissues. In the axillary lymph node
4 d.p.i., the expression patterns of DC-SIGN and MAC387
indicated two distinct cell populations, although co-localization
was observed in a relatively small number of cells (Figure 3D).
These data show that DC-SIGN is expressed predominantly by
DCs and some macrophages in the lungs and lymph nodes in
uninfected and MV-infected animals.
Macaque DC-SIGN Binds MV and Transmits the Virus to
Target Cells
Human DC-SIGN is an attachment receptor for MV and
mediates both infection of DCs (via CD150) and transmission to
target cells (via CD150 or PVRL4), which can be independent of
infection of DCs [13,18]. Non-human primate homologues are
$94% identical to human DC-SIGN and share a high affinity for
ICAM-2, ICAM-3 and cross-react with multiple monoclonal
antibodies against human DC-SIGN [21]. We investigated
whether macDC-SIGN binds MV and is able to transmit the
virus to target cells. Chinese hamster ovary (CHO) cells transfected
with macDC-SIGN expressed high levels of DC-SIGN, but were
negative for MV entry receptor CD150 (Figure 4A). Next we
investigated the interaction of macDC-SIGN with different
mannose- and fucose-containing structures using the fluorescent
bead binding assay [17]. CHO cells expressing macDC-SIGN
efficiently interacted with mannose, fucose and fucose-containing
structures such as Lewis X and Lewis Y (Figure 4B). Furthermore,
macDC-SIGN-expressing CHO cells interacted strongly with the
HIV-1 envelope glycoprotein gp120. The interaction was specific
for macDC-SIGN since antibodies against DC-SIGN blocked the
binding to background levels comparable to the parental cell-line
(Figure 4B). To investigate interaction of macDC-SIGN with MV,
CHO cells expressing macDC-SIGN cells were incubated with
FITC-labeled MV. MacDC-SIGN+ CHO cells bound MV as
determined by flow cytometry (Figure 4C). Binding to fluorescent
virus particles was macDC-SIGN-dependent, since it was inhibited
by a blocking antibody against DC-SIGN compared to the isotype
control. Incubation of CHO and CHO-macDC-SIGN cells with
rMVKSEGFP for 48 hours did not lead to infection, showing that
macDC-SIGN does not facilitate MV entry (Figure 4D). To
investigate the role of macDC-SIGN in MV transmission, cells
were incubated with rMVKSEGFP, washed and subsequently co-
cultured with CD150+ Raji B cells for 24 hours. CHO cells
expressing macDC-SIGN transmitted MV to the B cells. Pre-
treating cells with mannan or DC-SIGN blocking antibodies
decreased transmission to background levels (Figure 4E). Thus,
macDC-SIGN interaction with MV mediates viral binding and
transmission of the virus to lymphocytes independent of infection.
DC-SIGN+ Cells from Both BAL and Lymph Nodes
Transmit MV to Lymphocytes
Next we investigated whether DC-SIGN+ cells of macaques
transmit MV to lymphocytes ex vivo. DC-SIGNhi/HLA-DR+, DC-
SIGNlo/HLA-DR+ and DC-SIGN2/HLA-DR- cells were purified
by flow cytometry sorting from BAL and lymphoid tissues of
uninfected macaques (Figure 5A). In addition to these 3
populations, we detected a small DC-SIGN+/HLA-DR- in BAL
(designated as p4 in Figure 5A). However this population consisted
of too few cells for additional phenotyping. Expression of DC-
SIGN following sorting was confirmed at both the protein and
mRNA level (data not shown). Functionality of DC-SIGN
expressed by the sorted cells from BAL was investigated with the
bead binding assay (Figure 5B). DC-SIGNhi cells interacted with
HIV-1 gp120, which was inhibited by mannan. The other subsets
interacted much less with HIV-1 gp120. Similar results were
obtained with cells from TBLN (not shown), supporting a role for
macDC-SIGN+ cells in virus capture.
CD150 was expressed by a subpopulation of DC-SIGN2/HLA-
DR- cells, which included T and B lymphocytes, in BAL. Low
CD150 expression was detected on most cells in TBLN. DC-
SIGNhi/HLA-DR+ and DC-SIGNlo/HLA-DR+ cells expressed
very low levels of CD150 in BAL and the receptor was not
detected on the cell-surface on DC-SIGNlo/HLA-DR+ cells in
TBLN (Figure 5C). These data suggest that the HLA-DR+ cells in
Figure 1. Infection of DC-SIGN+ cells in the lung. (A) Infection of the DC-SIGNhi, DC-SIGNlo and DC-SIGN- cells in BAL from MV-infected
macaques, determined by detection of EGFP in flow cytometry at day 2–5 d.p.i. Each dot represents an individual animal. Lines indicate geometric
means. (B) Macroscopic images from EGFP+ lung slices collected 3 d.p.i., cultured for additional 3,5,7 or 10 days. (C) Phenotype of cells migrating from
the ex vivo cultured lung slice, collected from supernatant after 5 days of culturing (D) Phenotype of EGFP+ cells collected from lung slice medium. (E-
F) DC-SIGN expression on lung sections from uninfected macaques (E) or 2.d.p.i. (F) Asterisks indicate DC-SIGN reactivity.
doi:10.1371/journal.pone.0049573.g001
Figure 2. Infection in the tracheo-bronchial lymph nodes. Infection of the DC-SIGNhi, DC-SIGNlo and DC-SIGN- cells in TBLN from MV-infected
macaques, determined by detection of EGFP in flow cytometry from 2–5 d.p.i. Each dot represents an individual animal. Lines indicate geometric
means.
doi:10.1371/journal.pone.0049573.g002
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the lungs are not highly susceptible to MV infection without
activation. However, we showed that DC-SIGN is able to capture
MV for transmission. Therefore, we investigated the interaction of
the different cells with fluorescently labeled MV. Notably, DC-
SIGNhi cells isolated from lymphoid tissue bound more efficiently
to fluorescently-labeled MV and the binding was blocked to
background levels with the inhibitor mannan. In contrast, DC-
SIGNlo and DC-SIGN- cells did not bind MV (Figure 5D). These
data strongly suggest that despite low expression of CD150, the
Figure 3. DC-SIGN is expressed by DCs and a subset of macrophages in lymph nodes. (A) TBLN cells were stained for DC-SIGN in
combination with DC and macrophage markers and analyzed by flow cytometry. Gray areas show negative controls (DC-SIGN single staining).
Percentages of positive cells expressing the markers are annotated in the upper right corner. (B) DC-SIGN expression of CD11c+ and CD83+ cells in
TBLNs. (C-D) Dual immunofluorescence staining of DC-SIGN (green) and MAC387 (red) in lung sections 2 or 3 d.p.i. (C i-iv) and axillary lymphoid tissue
4 d.p.i. (D). Nuclei are stained blue with Hoechst.
doi:10.1371/journal.pone.0049573.g003
Figure 4. Macaque DC-SIGN binds mannose structures including MV and transmits MV to CD150+ target cells. (A) CHO cells were
transfected with macDC-SIGN. The mean expression levels of DC-SIGN and CD150 of the parental cell line and transfectants are depicted. Gray areas
represent isotype controls. (B) MacDC-SIGN binds mannose and fucose structures on fluorescent beads. Binding was blocked by anti-DC-SIGN (20 ug/
ml. (C) CHO transfectants were pre-incubated with anti-DC-SIGN antibodies or isotype control (20 ug/ml) before incubation with FITC-labeled UV-
inactivated MV. Binding was measured by flow cytometry. (D) Parental and transfected CHO cells were infected with rMVKSEGFP (MOI 1) and 48 hours
post infection EGFP levels were measured in FACS. (E) Cells were incubated with rMVKSEGFP (MOI 3). After 3 hours cells were washed and CD150+ Raji
cells were added to the culture. Infection of Raji cells was determined by measuring EGFP in flow cytometry. Transmission was blocked by pre-
incubating CHO macDC-SIGN cells with anti-DC-SIGN (20 ug/ml) or mannan (0.25 mg/ml). All data are representatives for at least 2 independent
experiments. Error bars represent standard deviations of duplicates.
doi:10.1371/journal.pone.0049573.g004
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Figure 5. DC-SIGN expressed by BAL and lymph node cells enhances MV transmission. (A) DC-SIGNhi/HLA-DR+ (p1), DC-SIGNlo/HLA-DR+
(p2) and HLA-DR2/DC-SIGN- (p3) cells were sorted by FACS from BAL and lymphoid tissues of uninfected animals. Gates and percentages of the
subsets are depicted. A representative FACS plot of 3 independent experiments is shown. (B) DC-SIGN on sorted BAL cells binds HIV-1 gp120-coated
fluorescent beads. Binding was blocked by mannan (0.25 mg/ml). Representative data of 2 independent experiments are shown. (C) CD150
expression of the 3 subsets from BAL and TBLN (black lines) compared to isotype controls (gray areas). Percentages of CD150+ cells are depicted in
the histograms. (D) Sorted cells from lymph nodes of an uninfected animal were incubated with fluorescently labeled rMVKSEGFP or medium control.
Binding was measured by flow cytometry and the mean fluorescent intensity (MFI) is depicted. (E) Representative example of 2 indepedent ex vivo
infections of BAL cells with rMVKSEGFP (MOI 3) 24 hours post infection. The left (brightfield) and right (EGFP fluorescent) panel are corresponding
pictures. (F) Infection of sorted DC-SIGN subsets with rMVKSEGFP (MOI 3) was determined by measuring EGFP in FACS. Means and standard deviations
of 2 independent experiments are shown. (G-H) Cells were incubated with rMVKSEGFP (MOI 1) for 3 hours. Then the cells were washed and B cells
were added. After 24 hours EGFP expression was measured by flow cytometry. For BAL cells, combined data of 2 independent experiments are shown
(G). Cells isolated from lymph nodes were pre-incubated with blocking anti-DC-SIGN antibodies (20 ug/ml) for 30 minutes. ** p,0.01 (H). Bars
represent the mean of duplicates.
doi:10.1371/journal.pone.0049573.g005
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DC-SIGNhi cells in contrast to DC-SIGNlo and DC-SIGN- cells
efficiently capture MV.
We subsequently investigated the transmission of MV to Raji B
cells by the different subsets isolated from uninfected macaques. Ex
vivo infection of unsorted BAL cells was inefficient and only 1%
EGFP+ cells was detected 24 hours after infection with
rMVKSEGFP (MOI 3). However, microscopic analysis showed
that a number of infected cells in the total BAL cell population
showed a DC-like morphology (Figure 5E). Ex vivo infection levels
of the sorted DC-SIGN/HLA-DR subsets were below 0.5%
24 h.p.i., and no differences were observed between subsets
(Figure 5F). Inefficient infection of ex vivo sorted cell populations
might indicate that lung factors facilitate infection in vivo. Thus,
transmission by the sorted cells to B cells was primarily due to
infection independent of direct infection of the subsets. The
different purified cell populations from BAL were pulsed with
rMVKSEGFP for three hours, and after washing CD150+ Raji
cells or B-LCL cells were added. Infection of the lymphocytes was
measured in the co-culture at day 1 or 2 by flow cytometry.
Notably, we observed a higher transmission of MV to target
lymphocytes by the DC-SIGNhi cells compared to both DC-
SIGNlo/HLA-DR+ and DC-SIGN2/HLA-DR- subsets
(Figure 5G). Similarly, transmission of MV by DC-SIGN+ subsets
isolated from TBLNs was significantly higher compared to DC-
SIGNlo/HLA-DR+ and DC-SIGN2/HLA-DR- subsets. Trans-
mission of MV by DC-SIGNhi/HLA-DR+ cells was partially
dependent on DC-SIGN, since it was inhibited by blocking
antibodies against DC-SIGN (Figure 5H). These data suggest that
DC-SIGN+ cells capture MV and facilitate infection of lympho-
cytes, thereby amplifying local and systemic spread.
Discussion
In this study we have investigated the role of DC-SIGN+ DCs
during the early stage of MV infection using both in vivo and ex vivo
models. After aerosol infection of macaques with the pathogenic
rMVKSEGFP strain, we observed that DC-SIGNhi DCs were
among the first infected cells in the lungs of macaques. These cells
were sorted by flow cytometry and DC-SIGNhi DCs were efficient
in MV capture as well as MV transmission to lymphocytes.
Furthermore, using cell-lines expressing macDC-SIGN we showed
that macDC-SIGN is an attachment receptor for MV, similar to
human DC-SIGN. This suggests that DC-SIGN+ DCs are an
initial target for MV for viral transmission and thereby contribute
to viral dissemination upon aerosol infection. Notably, although
we detected MV-infected DC-SIGNhi cells at the earliest time
point in the lungs, DC-SIGNhi DCs as well as macDC-SIGN-
transfected cells were able to transmit MV independent of
infection. Thus, transmission of MV to lymph nodes could depend
on infected as well as non-infected DC-SIGN+ cells in the lungs.
Epithelial cells in the upper respiratory tract have long been
considered as early target cells in MV infection [2]. Epithelial cells
express the recently identified entry receptor PVRL4 exclusively
on the basolateral side of the cells, and no CD150, and therefore
cannot play a role in initiation of infection [5,6]. DCs and AMs
have been proposed as initial target cells for the virus since these
cells express CD150 [18,20,22]. Non-human primate infection
studies have shown that large mononuclear cells in the lung are
early targets for MV after aerosol infection [20]. The identity of
these cells was not determined but it was suggested that these cells
disseminate MV infection from lungs to BALT and subsequently
to TBLNs draining the lungs [20]. Moreover, Ferreira et al, using
a transgenic mouse model after both intranasal and intraperitoneal
infection, observed MV infection of AMs and DCs in the airways
preceding infection in mediastinal lymph nodes [22]. Here, we
observed MV-infected DC-SIGNhi/HLA-DR+ cells 2 d.p.i.,
whereas no infected DC-SIGNlo/HLA-DR+ cells were identified
at that time point. DC-SIGN+ cells in the lungs were often located
in or adjacent to the lumen, where virus is encountered. The cells
were positive for CD11c, demonstrating that these cells are
myeloid and not plasmacytoid DCs. Therefore, DC-SIGN+ DCs
in macaque lungs could be a target for MV and play a role in
dissemination.
Furthermore, we observed the infection in the lungs spread
throughout foci, where mainly T cells were affected. Since DCs
are important for inducing BALT formation in response to viral
infections and for maintenance of the organized BALT structure
[23,24], DC-SIGN+ DCs might spread initial infection to BALT
and enhance local MV replication in the lungs, as well as activate
immune cells in BALT. A role for DCs in amplification of MV
infection in the lungs is supported by a previous finding where
MV-infected CD11c+ cells were observed in small infected foci in
the lungs from 3 d.p.i. [20]. In addition, CD11c+ DCs have been
identified as major target cells in peripheral tissues and were often
observed in conjunction with infected T lymphocytes, suggesting
viral transmission between the cells [10]. We observed from
3 d.p.i. that the infection in all animals spread to other cells
including the DC-SIGN2/HLA-DR- cells, which contain activat-
ed CD150+ lymphocytes. Furthermore, ex vivo lung cultures
showed that these cells become the predominant infected
population in lungs 8 d.p.i. Notably, although we measured
infection in vivo, we detected low levels of CD150 on DC-SIGNhi
cells from BAL and lymph nodes. This is consistent with previous
findings, where low levels of CD150 in the respiratory tract are
detected [18]. This could indicate that high levels of DC-SIGN
allow infection when CD150 expression is low, since DC-SIGN
enhances MV infection [13].
Previously, DC-SIGN was detected on cells expressing CD11c,
described as a marker for myeloid DCs and a subset of AMs in the
human lung [25,26] and in macaques no co-localization of
MAC387 and CD11c in BALT cells 3 d.p.i. was seen [20]. Here,
we observed that DC-SIGN was predominantly expressed by
CD11c+ DCs, whereas a subpopulation of MAC387+ macro-
phages expressed DC-SIGN. This subpopulation might represent
AMs since it has been described that AMs express DC-SIGN after
activation [27,28]. Pulmonary DCs are professional antigen
presenting cells and equipped to rapidly migrate to the draining
lymph node upon encountering virus in the lung [29–31]. Besides
their role as migratory antigen presenting cells, DCs also play
a major role in MV pathogenesis by contributing to infection and
immune suppression [2]. DC-SIGN contributes to these processes
since interactions with viral pathogens enhance infection and viral
uptake as well as modulate immune responses [14,17,18].
Furthermore, MV can induce TLR2 activation [32], which might
also be involved in DC-mediated immune responses as well as
induction of migration from lungs to LN. In contrast, AMs are
crucial for maintaining homeostasis in steady-state condition and
restoring homeostasis after infection [33]. This classical division of
DCs as migrating antigen presenting cells and macrophages as
tissue residents further supports a role for DCs transferring viruses
to lymphoid cells [17,18].
Our data show that at day 2 d.p.i. no MV infection was
observed in draining lymph nodes, whereas we detected MV-
infected DC-SIGNhi DCs in the lungs. At 4 d.p.i. we observed
MV infection of different cell types in draining lymph nodes,
suggesting that the virus had spread from lung to lymph nodes. In
our previous study, MV-infected cells with the morphology of DCs
were detected migrating through the endothelium early in
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infection [20], suggesting that infected or MV-bound DCs migrate
from the lungs to TBLNs to transmit the virus to T lymphocytes.
Migration of DCs after MV infection is further supported by
a strong induction of lymph node homing chemokine CCR7 [34].
In the TBLNs draining the lungs, DC-SIGN was mainly expressed
by CD11c+ DCs and DC maturation marker CD83+ DCs,
implying a role for these cells in immune activation.
We and others have shown that DC-SIGN functions as an
attachment receptor for viruses such as MV and HIV-1, which can
enhance infection thereby promoting transmission. However,
infection of DCs is not required for viral DC-SIGN-mediated
transmission [13,17,18]. Here we showed that macDC-SIGN
efficiently captured MV and transmitted it to lymphocytes
independent of MV infection. Further, isolated DC-SIGNhi cells
from the lungs or TBLNs bound MV and enhanced transmission
of the virus to B cells. DC-SIGN antibodies partially blocked
transmission, indicating that DC-SIGN was involved, but other
factors, such as heparan sulfates [35,36] might also contribute. B
cell infection could be a result of trans- or cis infection, although
inefficient infection of DC-SIGNhi cells supports the model of
transmission independent of DC infection in our ex vivo assays. We
therefore hypothesize that DC-SIGN+ cells, infected or uninfected,
facilitate transfer to lymphocytes that are the main replicators for
MV.
Overall, we have shown a role for DC-SIGN in MV trans-
mission, using a macaque infection model. Our results using
primary cells from the lungs and lymphoid tissue are in
concordance with the results previously obtained with human
monocyte-derived DCs [18]. In vitro studies of DC-SIGN-mediated
mechanisms however do not take into account the plasticity of the
phenotype and function of innate immune cell subsets [37,38].
Taken together, these data support the idea that MV targets HLA-
DR+ cells, including DC-SIGN+ cells, in the lungs directly after
infection. This study provides a better understanding of initiation
of MV infection in vivo, which may be beneficial for development
of an aerosol- or powder-delivered vaccine [39–42] to increase
immunization coverage.
Materials and Methods
Ethics Statement
Animal experiments were conducted in compliance with
European guidelines (EU directive on animal testing 86/609/
EEC) and Dutch legislation (Experiments on Animals Act, 1997).
The protocol was approved by the independent animal experi-
mentation ethical review committee Dier Experimenten Commis-
sie in Driebergen, The Netherlands.
Animals were obtained from the National Institute of Public
Health and the Environment, Bilthoven, and transported to the
central animal housing facility of the Erasmus MC in Rotterdam.
The animals were housed in groups, received standard primate
feed and fresh fruit on a daily basis and had access to water ad
libitum. In addition, their cages contained several sources of
environmental enrichment in the shape of hiding places, hanging
ropes, tires and other toys. Animal welfare was observed on a daily
basis, animal handling was performed under light anesthesia using
ketamine and medetomidine. After handling atipamezole was
administered to antagonize the effect of medetomidine.
Animal Studies
The infection study was previously described by Lemon et al.
[20]. In short, MV-seronegative cynomolgus macaques (Macaca
fascicularis) were infected with an estimated dose of 105 CCID50
rMVKSEGFP via aerosol inhalation, using a pediatric face mask.
Animals were euthanized 2, 3, 4 or 5 d.p.i. (n = 3 per time point).
Animals were euthanized by sedation with ketamine (20 mg/kg
body weight) followed by exsanguination. For both experiments
with infected and uninfected animals, tissues were collected in PBS
and directly processed. A broncho alveolar lavage (BAL) was
performed post-mortem by direct infusion of 10 ml phosphate
buffered saline (PBS) into the right lung lobe. BAL cells were re-
suspended in RPMI1640 supplemented with L-glutamine (2 mM),
penicillin (100 U/ml), streptomycin (100 mg/ml) and 10% (v/v)
heat-inactivated fetal bovine serum (FBS), lymphoid organs were
collected during necropsy in PBS for direct preparation of single
cell suspensions. Suspensions were obtained by mashing the nodes,
using cell strainers with a 100 mm pore size (BD Biosciences) and
washing the cells in RPMI1640. Single cell suspensions and BAL
cells were counted and used directly for flow cytometry, FACS
sorting or ex vivo assays.
Lung Slices
The left lung lobe of 2 animals on 3 d.p.i. was inflated using
a solution of 4% (w/v) agarose in PBS mixed 1:1 with DMEM/
Ham’s F12 medium supplemented with L-glutamine (2 mM), 10%
(v/v) heat-inactivated FBS, penicillin (100 U/ml) and streptomy-
cin (100 mg/ml). The inflated lung was allowed to solidify on ice
and 1 mm slices were cut by hand. Sections were washed in PBS
and transferred to a 6-wells plate.
Antibodies
All antibodies used cross-react with macaques according to the
NIH Nonhuman Primate Reagent Resource or the manufacturer.
The following antibodies were used for flow cytometry and
blocking: DC-SIGN-specific mouse antibodies AZN-D1 and
AZN-D2 [17], DCN46 conjugated with PE (BD Pharmingen,
San Diego, CA, USA), fab161A conjugated with APC (R&D
Systems, Minneapolis, USA), HLA-DR- (L243) specific mouse
antibodies conjugated with pacific blue (biolegend, San Diego,
CA, USA), MAC387 (Abcam, Cambridge UK), PE-conjugated
CD11c (S-HCL-3) mouse antibodies (Becton Dickinson, New
Jersey, USA), PE-conjugated mouse antibody CD83 (HB15A;
Beckman Coulter, Miami Florida, USA), PE-conjugated mouse
antibody CD163 (GHI/61; ebioscience, San Diego, CA, USA),
CD150 antibody (A12; ABD Serotec, Dusseldorf, Germany),
Alexa488- or Alexa647-labeled anti-mouse antibodies (Molecular
probes, Eugene, OR, USA). MV infection was detected via EGFP
in the FITC channel of the flow cytometer.
Cell Lines and Viruses
Stable CHO transfectants expressing rhesus macaque DC-
SIGN [Genbank AF391086] were generated using pRc/CMV-rh-
DC-SIGN as previously described [17]. CHO cells expressing
macaque DC-SIGN were selected with neomycin (1 mg/ml).
CHO, Raji and Epstein-Barr virus-transformed B-lymphoblastic
cell line (BLCL-GR) were cultured in RPMI1640 supplemented
with L-glutamine (2 mM), penicillin (100 U/ml), streptomycin
(100 mg/ml) and 10% (v/v) FCS. Generation of rMVKSEGFP for
animal studies is described by Lemon et al. [20]. For ex vivo
infection and transmission assays, rMVKSEGFP and rMVI-
C323EGFP were propagated on B-LCL cells or Vero-CD150 cells
and titrated on Vero-CD150 cells for titer determination.
FACS Analysis and Sorting
Flow cytometry was performed on a FACS Canto II or
FACScan (BD Bioscience San Jose, CA, USA). Cell sorting was
performed on a BD FacsAria. For all experiments, cells were
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washed in PBS/0.5% BSA and incubated with directly-labeled
antibodies (1–5 mg/ml) or isotype controls (BD, San Jose, CA) for
30 minutes at 4uC. Samples were fixed with 4% (w/v) para-
formaldehyde before measuring. Samples were analyzed by Cell
Quest Pro software (BD Biosciences, San Jose, CA, USA) and
experiments were analyzed using FlowJo 7.6.3 software (Tree star
inc.).
Immunohistochemical and Indirect Immunofluorescence
Analysis
Formalin-fixed tissues were processed to paraffin. Consecutive
sections (7 mm) from lung and lymphoid tissues were cut.
Immunocytochemical staining was performed using a BondMax
immunostainer with a polymer-based peroxidase detection system.
DC-SIGN+ cells were detected using a monoclonal antibody to
DC-SIGN (Invitrogen, ER2 antigen retrieval). Dual labeling
indirect immunofluorescence was performed using monoclonal
mouse antibodies macrophage marker MAC387 (Abcam, Cam-
bridge UK) and DC-SIGN Mab161 (R&D Systems, Minneapolis,
USA). Mab161 and MAC387 antibodies were visualized with
a mixture of anti IgG1 and IgG2b conjugated with Alexa 546 or
Alexa 488 (Molecular probes, Eugene, OR, USA). Nuclei were
counterstained with Hoechst (Molecular probes, Eugene, OR,
USA). All fluorescent stained slides were assessed with a Leica
DMRA microscope and processed using Image Pro Plus software
(Media Cybernatics). Matched isotype antibodies (BD, San Jose,
CA, USA) served as negative control and were essentially blank.
MV Infection and transmission Assays
For infection and transmission assays cells (10–506103) were
seeded in a V-bottom plate and pre-incubated with mannan
(0.25 mg/ml; Sigma-Aldrich, Zwijndrecht, Netherlands), anti-DC-
SIGN (AZN-D1 or AZN-D2; 20 mg/ml) or IgG1 isotype control
(20 mg/ml; BD, San Jose, CA, USA) for 30 minutes at 37uC,
before incubation with rMVIC323EGFP or rMVKSEGFP at
a multiplicity of infection (MOI) of 1–3 at 37uC for 24 hours in
the case of infection. For transmission, after 2 hours the cells were
washed and Raji (56104 cells) were added. After one to three days
cells were harvested, washed and fixed with 4% (w/v) para-
formaldehyde and EGFP expression was measured by flow
cytometry. The gate for both populations was set at the uninfected
control sample.
Fluorescent Bead Adhesion Assay
The fluorescent bead adhesion assay was performed as de-
scribed before [17]. In short, streptavidin was covalently coupled
to carboxylate-modified TransFluorSpheres (488/645 nm by
1.0 mm; Molecular Probes, Eugene, OR, USA). The streptavi-
din-coated beads were incubated with biotinylated-sugars (Glyco-
tech, Gaithersburg, MD, USA) at 4uC or biotinylated Goat-anti-
human Fc (Jackson Immunoresearch, Baltimore, PA, USA) at
37uC and subsequently gp120 Fc at 4uC. The coated beads were
added to cells at a ratio of 20:1. Cells (10–206103) were incubated
with beads for 45 minutes at 37uC. Mannan (0.25 mg/ml; Sigma-
Aldrich, Zwijndrecht, Netherlands) and blocking antibodies
against DC-SIGN (20 mg/ml) were used to determine the
specificity of the adhesion. Binding was measured by flow
cytometry.
FITC-labeled MV Binding Assay
To generate FITC-labeled viruses, purified rMVIC323EGFP
(2.46107 TCID50) was inactivated by dialyzing against 0.1% (w/
v) formalin for 72 hours at 4uC. Next, viruses were labeled with
FITC (0.1 mg/ml in 0.5 M bicarbonate buffer (pH 9.5) for 1 hour
with constant stirring. The virus preparations were dialyzed
against PBS overnight to remove unbound FITC. CHO cells
(206103) were plated in 96 well v-bottom plates and pre-incubated
with medium (RPMI 1640 medium, supplemented with L-
glutamine, 10% (v/v) FCS, penicillin and streptomycin), mannan
(0.25 mg/ml; Sigma-Aldrich, Zwijndrecht, Netherlands), blocking
antibodies against DC-SIGN (AZN-D1) or IgG1 isotype control
(BD, San Jose, CA) for 30 minutes at 37uC. Subsequently the cells
were incubated with 20 ml of virus preparation for 30 minutes at
37uC. Binding was measured by flow cytometry.
Fluorescently-labeled MV Binding Assay
MV labeling was performed as described by Hadac et al [43]. In
short, MV-FSL-FLRO4 virions were prepared by adding 10 ml of
FSL-FLRO4 (Kode Biotech, Auckland, New Zealand) (100 mg/
ml) to 100 ml of rMVKSEGFP (2.26106 TCID50) or 100 ml RPMI
(control), followed by incubation for 2 hours at 37uC. 20 ml of the
prepared MV-FSL-FLRO4 or FLRO4-medium control was
added to sorted cells (206103) in RPMI medium and incubated
at 37uC for 30 minutes. Mannan (0.25 mg/ml; Sigma-Aldrich,
Zwijndrecht, Netherlands) was used to determine the specificity of
the binding. Following incubation the cells were washed and then
fixed in 4% (w/v) paraformaldehyde before flow cytometry.
Statistical Analysis
To evaluate differences between groups, a t test was used.
P,0.05 was considered significant.
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